Patent · US Active

Compounds involving mGluR5 receptor regulation and methods of making the compounds

US8318774B2 · kind B2 · utility

0Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2008
Grant dateNov 27, 2012
Priority date
Expiry dateFeb 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

3-((Thiazol-2-yl)amino)propylproiolamide compounds of the formula I:wherein the variables are as defined herein, are useful to prevent or treat a disease or disorder involving mGluR5 receptor regulation. Also disclosed are pharmaceutical compositions containing the compounds and methods of making the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.